FI956203A - Lisääntyneen biologisen aktiivisuuden omaava katkaistu keratinosyyttika sivutekijä (KGF) - Google Patents
Lisääntyneen biologisen aktiivisuuden omaava katkaistu keratinosyyttika sivutekijä (KGF) Download PDFInfo
- Publication number
- FI956203A FI956203A FI956203A FI956203A FI956203A FI 956203 A FI956203 A FI 956203A FI 956203 A FI956203 A FI 956203A FI 956203 A FI956203 A FI 956203A FI 956203 A FI956203 A FI 956203A
- Authority
- FI
- Finland
- Prior art keywords
- kgf
- biological activity
- increased biological
- side factor
- keratinocyte
- Prior art date
Links
- 230000004071 biological effect Effects 0.000 title 1
- 210000002510 keratinocyte Anatomy 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 102000057239 human FGF7 Human genes 0.000 abstract 2
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 abstract 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8642793A | 1993-06-29 | 1993-06-29 | |
PCT/US1994/004694 WO1995001434A1 (fr) | 1993-06-29 | 1994-04-28 | Un facteur de croissance des keratinocytes (kgf) tronque a activite biologique accrue |
Publications (2)
Publication Number | Publication Date |
---|---|
FI956203A0 FI956203A0 (fi) | 1995-12-22 |
FI956203A true FI956203A (fi) | 1996-02-07 |
Family
ID=22198501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI956203A FI956203A (fi) | 1993-06-29 | 1995-12-22 | Lisääntyneen biologisen aktiivisuuden omaava katkaistu keratinosyyttika sivutekijä (KGF) |
Country Status (25)
Country | Link |
---|---|
US (7) | US5677278A (fr) |
EP (2) | EP1493812A3 (fr) |
JP (4) | JP3570516B2 (fr) |
KR (1) | KR960703433A (fr) |
CN (1) | CN1129955A (fr) |
AT (1) | ATE278777T1 (fr) |
AU (1) | AU681405B2 (fr) |
BG (1) | BG100236A (fr) |
BR (1) | BR9407035A (fr) |
CA (1) | CA2166278A1 (fr) |
CZ (1) | CZ343795A3 (fr) |
DE (2) | DE69434053T2 (fr) |
DK (1) | DK0706563T3 (fr) |
ES (1) | ES2227527T3 (fr) |
FI (1) | FI956203A (fr) |
FR (1) | FR06C0004I2 (fr) |
HU (1) | HUT73453A (fr) |
LU (1) | LU91215I2 (fr) |
NL (1) | NL300217I2 (fr) |
NO (1) | NO955189L (fr) |
NZ (1) | NZ266622A (fr) |
PL (1) | PL312257A1 (fr) |
PT (1) | PT706563E (fr) |
SK (1) | SK153295A3 (fr) |
WO (1) | WO1995001434A1 (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2153816T3 (es) | 1989-01-31 | 2001-03-16 | Jeffrey S Rubin | Adn que codifica un factor de crecimiento especifico contra celulas epiteliales. |
US7026291B1 (en) | 1989-01-31 | 2006-04-11 | The United States Of America As Represented By The Department Of Health And Human Services | Epithelial cell specific growth factor, keratinocyte growth factor (KGF) |
US5814605A (en) * | 1993-03-26 | 1998-09-29 | Amgen Inc. | Therapeutic uses of keratinocyte growth factor |
BR9407035A (pt) * | 1993-06-29 | 1996-03-12 | Chiron Corp | Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme |
US7084119B2 (en) * | 1993-06-29 | 2006-08-01 | Chiron Corporation | Truncated keratinocyte growth factor (KGF) having increased biological activity |
AU745815B2 (en) * | 1994-10-13 | 2002-04-11 | Biovitrum Ab (Publ) | Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using |
CZ98297A3 (cs) * | 1994-10-13 | 1998-08-12 | Amgen Inc. | Způsob purifikace keratinocytových růstových faktorů |
WO1996011949A2 (fr) * | 1994-10-13 | 1996-04-25 | Amgen Inc. | Analogues du facteur de croissance de keratinocytes |
US6008328A (en) * | 1994-10-13 | 1999-12-28 | Amgen Inc. | Method for purifying keratinocyte growth factors |
US7232667B2 (en) | 1995-02-14 | 2007-06-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 polynucleotides |
US6693077B1 (en) | 1995-02-14 | 2004-02-17 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
US6077692A (en) * | 1995-02-14 | 2000-06-20 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
EP1486565B1 (fr) | 1995-10-11 | 2007-11-21 | Novartis Vaccines and Diagnostics, Inc. | Combinaison de PDGF, de KGF, d'IGF et d'IGFBP pour guérir les blessures |
US6692961B1 (en) | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
SI0935652T1 (en) * | 1996-10-15 | 2004-06-30 | Amgen Inc. | Keratinocyte growth factor-2 products |
GB2322132B (en) * | 1996-10-15 | 1999-09-22 | Amgen Inc | Keratinocyte growth factor-2 products |
US20030144202A1 (en) * | 1996-10-15 | 2003-07-31 | Amgen Inc. | Uses of keratinocyte growth factor-2 |
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
EP1003770A4 (fr) * | 1997-06-19 | 2002-10-30 | Inst Genetics Llc | Proteines secretees et polynucleotides codant ces proteines |
US20080233086A1 (en) * | 1997-09-05 | 2008-09-25 | Canbiocin Inc. | Expression Vectors for Treating Bacterial Infections |
US6869927B1 (en) | 1997-12-22 | 2005-03-22 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
CA2316015A1 (fr) * | 1997-12-22 | 1999-07-01 | Human Genome Sciences, Inc. | Formulations du facteur-2 de croissance des keratinocytes |
WO1999041282A1 (fr) * | 1998-02-13 | 1999-08-19 | Human Genome Sciences, Inc. | Utilisations therapeutiques du facteur-2 de croissance de keratinocyte |
DE19934510B4 (de) * | 1999-07-22 | 2009-04-16 | Vermicon Ag | Verfahren zum Nachweis von Mikroorganismen |
AU2039501A (en) | 1999-10-15 | 2001-04-23 | Rockefeller University, The | System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae |
DE10024334B4 (de) * | 2000-05-17 | 2006-06-01 | Medigene Ag | Verfahren zum Einbringen von Nukleinsäure in eine Zelle (Transfektion) mittels Calciumphosphat |
AU2002236477A1 (en) | 2000-11-21 | 2002-06-03 | The Texas A & M University System | Fgf-affinity chromatography |
US20030186904A1 (en) * | 2001-01-08 | 2003-10-02 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
CA2438652A1 (fr) | 2001-02-19 | 2002-09-06 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Procede d'identification d'epitopes de lymphocytes t et utilisation dans la preparation de molecules a immunogenicite reduite |
MXPA04001526A (es) * | 2001-08-21 | 2004-05-31 | Chiron Corp | Composiciones de polipetidos kgf. |
US7202066B2 (en) * | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
GB0426394D0 (en) | 2004-12-01 | 2005-01-05 | Health Prot Agency | Fusion proteins |
KR101283736B1 (ko) * | 2004-12-15 | 2013-07-08 | 스위디쉬 오르펀 바이오비트럼 에이비(피유비엘) | 케라티노사이트 성장 인자의 치료학적 제형 |
US20060183712A1 (en) * | 2005-02-17 | 2006-08-17 | The Texas A&M University System | Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor |
CA2630220C (fr) * | 2005-11-22 | 2020-10-13 | Doris Coit | Antigenes de norovirus et de sapovirus |
GB0611405D0 (en) * | 2006-06-09 | 2006-07-19 | Univ Belfast | FKBP-L: A novel inhibitor of angiogenesis |
WO2008005533A2 (fr) * | 2006-07-06 | 2008-01-10 | Aaron Thomas Tabor | Compositions et procédés de modification génétique de cellules ayant une fonction cosmétique pour l'amélioration de l'aspect cosmétique |
KR101021197B1 (ko) * | 2008-04-11 | 2011-03-11 | (주)케어젠 | 성장인자―미미킹 펩타이드 및 그의 용도 |
EP2454368A4 (fr) | 2009-07-17 | 2013-01-09 | Aaron Thomas Tabor | Compositions et procédés pour la modification génétique de cellules ayant une fonction cosmétique afin d'améliorer l'aspect cosmétique |
MX2016005614A (es) | 2013-11-01 | 2016-12-09 | Spherium Biomed S L | Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos. |
CA3227834A1 (fr) | 2021-08-30 | 2023-03-09 | Dhananjay Sathe | Compositions de proteines pour le traitement de maladies inflammatoires |
KR20230070596A (ko) * | 2021-11-15 | 2023-05-23 | (주)피앤피바이오팜 | 안정성이 증가된 인간 각질세포 성장인자1 변이체 및 이의 용도 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2153816T3 (es) | 1989-01-31 | 2001-03-16 | Jeffrey S Rubin | Adn que codifica un factor de crecimiento especifico contra celulas epiteliales. |
US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
US5814605A (en) | 1993-03-26 | 1998-09-29 | Amgen Inc. | Therapeutic uses of keratinocyte growth factor |
BR9407035A (pt) | 1993-06-29 | 1996-03-12 | Chiron Corp | Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme |
MX9702665A (es) | 1994-10-13 | 1997-07-31 | Amgen Inc | Analogos del factor de crecimiento de queratinocitos. |
WO1996011949A2 (fr) | 1994-10-13 | 1996-04-25 | Amgen Inc. | Analogues du facteur de croissance de keratinocytes |
-
1994
- 1994-04-28 BR BR9407035A patent/BR9407035A/pt not_active Application Discontinuation
- 1994-04-28 NZ NZ266622A patent/NZ266622A/en unknown
- 1994-04-28 KR KR1019950705997A patent/KR960703433A/ko not_active Application Discontinuation
- 1994-04-28 ES ES94916597T patent/ES2227527T3/es not_active Expired - Lifetime
- 1994-04-28 HU HU9503857A patent/HUT73453A/hu unknown
- 1994-04-28 DE DE69434053T patent/DE69434053T2/de not_active Expired - Lifetime
- 1994-04-28 CZ CZ953437A patent/CZ343795A3/cs unknown
- 1994-04-28 AT AT94916597T patent/ATE278777T1/de active
- 1994-04-28 WO PCT/US1994/004694 patent/WO1995001434A1/fr active IP Right Grant
- 1994-04-28 SK SK1532-95A patent/SK153295A3/sk unknown
- 1994-04-28 EP EP04023638A patent/EP1493812A3/fr not_active Ceased
- 1994-04-28 DK DK94916597T patent/DK0706563T3/da active
- 1994-04-28 AU AU68208/94A patent/AU681405B2/en not_active Ceased
- 1994-04-28 CA CA002166278A patent/CA2166278A1/fr not_active Abandoned
- 1994-04-28 DE DE1994634053 patent/DE122006000005I2/de active Active
- 1994-04-28 JP JP50346495A patent/JP3570516B2/ja not_active Expired - Fee Related
- 1994-04-28 CN CN94193193A patent/CN1129955A/zh active Pending
- 1994-04-28 PT PT94916597T patent/PT706563E/pt unknown
- 1994-04-28 PL PL94312257A patent/PL312257A1/xx unknown
- 1994-04-28 EP EP94916597A patent/EP0706563B1/fr not_active Expired - Lifetime
-
1995
- 1995-03-27 US US08/410,941 patent/US5677278A/en not_active Expired - Lifetime
- 1995-06-06 US US08/468,547 patent/US5843883A/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,937 patent/US5863767A/en not_active Expired - Lifetime
- 1995-06-06 US US08/468,546 patent/US5773586A/en not_active Expired - Lifetime
- 1995-12-20 NO NO955189A patent/NO955189L/no unknown
- 1995-12-20 BG BG100236A patent/BG100236A/xx unknown
- 1995-12-22 FI FI956203A patent/FI956203A/fi unknown
-
1998
- 1998-05-08 US US09/074,950 patent/US6074848A/en not_active Expired - Lifetime
-
2000
- 2000-05-16 US US09/573,068 patent/US6677301B1/en not_active Expired - Fee Related
-
2004
- 2004-02-10 JP JP2004034289A patent/JP2004166709A/ja not_active Withdrawn
-
2005
- 2005-11-17 JP JP2005333438A patent/JP2006075173A/ja not_active Withdrawn
-
2006
- 2006-01-26 NL NL300217C patent/NL300217I2/nl unknown
- 2006-01-27 LU LU91215C patent/LU91215I2/en unknown
- 2006-01-31 FR FR06C0004C patent/FR06C0004I2/fr active Active
-
2007
- 2007-06-11 US US11/811,560 patent/US20090093400A1/en not_active Abandoned
-
2008
- 2008-11-26 JP JP2008301630A patent/JP4662569B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI956203A0 (fi) | Lisääntyneen biologisen aktiivisuuden omaava katkaistu keratinosyyttika sivutekijä (KGF) | |
IT8752870V0 (it) | Attuatore lineare elettromeccanico per il ribaltamento della cabina di guida di un veicolo industriale | |
DK0397633T3 (da) | Fibronectinbindende protein samt fremstilling deraf | |
ITRM940820A0 (it) | "composizione per il controllo degli insetti nocivi" | |
DE69024862D1 (de) | Modifiziertes, biologisch aktives Protein | |
ES2088860T3 (es) | Activador plasminogenico de tipo tisular humano modificado y su preparacion. | |
DE69024104D1 (de) | Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase | |
DE69126049D1 (de) | Vektoren und Zusammensetzungen zur Expression von Glykosilationsmutanten des menschlichen Proteins-C | |
DE122007000031I1 (de) | Für menschliches Papillomavirus stamm 18 kodierende DNS | |
HUT51647A (en) | Process for production of reduced non-glycolized recombined human il under 2 | |
SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
ATE145939T1 (de) | Mitogen für die glatte muskulatur und dessen kodierende dns | |
IT1231764B (it) | Composizione poliuretanica con capacita' di assorbire umidita', particolarmente adatta per la fabbricazione di cuoio sintetico e simili, e procedimento per la sua produzione. | |
EP0206329A3 (en) | Sprung floor | |
AU4064293A (en) | Textile material | |
DE3877015D1 (de) | Antikoerper enthaltende stabilisierte waesserige zusammensetzung. | |
ATE310083T1 (de) | Deprenyl induziertes protein | |
ATE290598T1 (de) | Neue staphylokinase derivate | |
IT9021117V0 (it) | Leva di comando particolarmente per l'azionamento di gruppi valvolari | |
BR9302320A (pt) | Aperfeiçoamento aplicado em estampo de repuxo de tampo de reservatório de compressor de ar ou outros | |
TH22943A (th) | รีคอมบิแนนท์โปรตีนที่กำหนดเป็น dev-1 ที่มีประโยชน์สำหรับตรวจหา hiv ลำดับดีเอนเอที่ประมวลรหัสของโปรตีนและการวิเคราะห์ทางอิมมูนโดยใช้โปรตีนนี้ | |
IT8720590A0 (it) | Composti ad attivita' nootropa. | |
IT1214780B (it) | Supporto setole,per scope o simili,con l'intradosso arcuato e la pianta di forma quadrangolare tetracuspidata |